Bruker Corp. (BRKR)
61.56
+1.23
(+2.04%)
USD |
NASDAQ |
Nov 13, 16:00
61.56
0.00 (0.00%)
After-Hours: 17:09
Bruker EPS Diluted (Quarterly) : -0.8052 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.8052 |
| June 30, 2026 | -0.413 |
| March 31, 2026 | 0.0229 |
| December 31, 2025 | 0.0977 |
| September 30, 2025 | -0.4111 |
| June 30, 2025 | 0.0501 |
| March 31, 2025 | 0.1146 |
| December 31, 2024 | 0.0901 |
| September 30, 2024 | 0.2691 |
| June 30, 2024 | 0.0514 |
| March 31, 2024 | 0.3489 |
| December 31, 2023 | 1.408 |
| September 30, 2023 | 0.5981 |
| June 30, 2023 | 0.3866 |
| March 31, 2023 | 0.5183 |
| December 31, 2022 | 0.6586 |
| September 30, 2022 | 0.5929 |
| June 30, 2022 | 0.3304 |
| March 31, 2022 | 0.4069 |
| December 31, 2021 | 0.4964 |
| September 30, 2021 | 0.57 |
| June 30, 2021 | 0.3767 |
| March 31, 2021 | 0.3701 |
| December 31, 2020 | 0.448 |
| September 30, 2020 | 0.3519 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.1558 |
| March 31, 2020 | 0.0676 |
| December 31, 2019 | 0.4414 |
| September 30, 2019 | 0.394 |
| June 30, 2019 | 0.2316 |
| March 31, 2019 | 0.1951 |
| December 31, 2018 | 0.4962 |
| September 30, 2018 | 0.2757 |
| June 30, 2018 | 0.1987 |
| March 31, 2018 | 0.172 |
| December 31, 2017 | -0.0218 |
| September 30, 2017 | 0.2331 |
| June 30, 2017 | 0.15 |
| March 31, 2017 | 0.13 |
| December 31, 2016 | 0.43 |
| September 30, 2016 | 0.29 |
| June 30, 2016 | 0.09 |
| March 31, 2016 | 0.14 |
| December 31, 2015 | 0.36 |
| September 30, 2015 | 0.07 |
| June 30, 2015 | 0.13 |
| March 31, 2015 | 0.04 |
| December 31, 2014 | 0.15 |
| September 30, 2014 | 0.03 |
| June 30, 2014 | 0.10 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Danaher Corp. | 1.747 |
| Thermo Fisher Scientific, Inc. | 4.639 |
| Bio-Rad Laboratories, Inc. | 17.02 |
| Harvard Bioscience, Inc. | -0.5751 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -109.70M |
| Revenue (Quarterly) | 874.00M |
| Total Expenses (Quarterly) | 985.80M |
| Enterprise Value | 10.82B |
| Gross Profit Margin (Quarterly) | 49.19% |
| Profit Margin (Quarterly) | -12.55% |
| Earnings Yield | -1.78% |
| Operating Earnings Yield | 3.77% |
| Normalized Earnings Yield | 1.158 |